Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 3 4Phase 1/2 4Phase 2 1

Status

Completed 63Active not recruiting 20Recruiting 9Terminated 4Withdrawn 2Not yet recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Genitourinary 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 92Breast Neoplasms 86Neoplasms 79Prostatic Neoplasms 50Lung Neoplasms 44Neoplasm Metastasis 40Colorectal Neoplasms 37Leukemia, Myeloid, Acute 32Pain 27Head and Neck Neoplasms 25Colonic Neoplasms 25Multiple Myeloma 24Ovarian Neoplasms 23Lymphoma 23Carcinoma, Hepatocellular 23Pancreatic Neoplasms 22Lymphoma, Follicular 21Melanoma 20Leukemia 20Rectal Neoplasms 19Lymphoma, Non-Hodgkin 19Urinary Bladder Neoplasms 17Recurrence 17Stomach Neoplasms 15Lymphoma, Large B-Cell, Diffuse 15Leukemia, Lymphocytic, Chronic, B-Cell 15Squamous Cell Carcinoma of Head and Neck 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Leiomyoma 13

Interventions

pembrolizumab 3Paclitaxel 2epacadostat 1Saline Solution 1Radiosurgery 1Prednisone 1Pemetrexed 1Nivolumab 1Gemcitabine 1Docetaxel 1Dexamethasone 1Cisplatin 1Carboplatin 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Parkinson Disease 4, Autosomal Dominant Lewy Body × Clear all
NCT03924869 2025-12-11

KEYNOTE-867

Merck Sharp & Dohme LLC

Phase 3 Terminated
448 enrolled 24 charts
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT04907227 2024-07-12

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Terminated
81 enrolled 19 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT03019588 2023-03-30

MK-3475-063

Merck Sharp & Dohme LLC

Phase 3 Terminated
94 enrolled 17 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT03348904 2019-06-13

Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer

Incyte Corporation

Phase 3 Terminated
2 enrolled 6 charts
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡